Sickle Cell is becoming a 'Sexy Chronic Disease' - $$

    Just returning from a Sickle Cell conference at the National Institute of Health in Bethesda, MD and am awl of the number of new clinical trials in the pipeline to develop new medicines to treat and cure Sickle Cell Disease.  Over the years, I witnessed having just a few medications to treat the horrible complications persons experience from the damage causes from the 'sickling' of the 

blood cells such as lung damage, heart enlargement and damage, kidney damage, joint and bone damage and etc.  

    The FDA recently approved new Drug called, Endari  aimed to reduce sickling of the red blood cells.  Although we are waiting for access to this medication, there is real hope on the Horizon.  There are also new Point of Care testing trials to rapidly diagnose people with sickle cell and trait and even in non-invasive 'no needle' stick methods.

To find out more about these new therapies, visit a 

Comprehensive Sickle Cell Treatment Center in your area.

Specialty Care Matters! 

Click this link to read the TOVA Press Release on Endari

Join TOVA for the 6th Annual Sickle Cell 5K Run/Walk on September 30th

at Brandywine Zoo.  Registration Opens at 9am and Race begins promptly 

at 10am.  Register at www.races2run.com

TOVA Community Health

Sickle Cell Specialty Treatment Center

213 Greenhill Ave., Suite B

Wilmington, DE 19805

(302) 429-5870 ext. 120-p

www.tovacommunityhealth.org

All the best, Dr. Nina

TOVA featured in Delaware Business Times: A whole new model of health care

TOVA Healthcare
in association with TOVA Community Health
(302) 429-5870 ext. 120 -phone
(302) 429-9284 - fax
www.tovacommunityhealth.org
2017 SBA Woman-Owned Business of the Year

                                                                   Delaware Business Times                                                 MAY 30, 2017 • VOL. 4 • NO. 11 • $2


TOVA Press Release: New Treatment approved for sickle cell in nearly 20 years

TOVA Community Health
213 Greenhill Ave., Suite B
Wilmington, DE 19805
302-429-5870 ext. 120
302-429-9284
contact@tovacommunityhealth.org
www.tovacommunityhealth.org

Blue Tag Sickle Cell Blood Drive Save Lives

Blue Tag Sickle Cell Blood Drive Sickle Cell Disease (SCD) affects approximately 80,000 African Americans nationwide. It can cause terrible pain, known as “crisis”, as well as organ and tissue damage, stroke, and anemia. Treatment for crisis, stroke and other complications may involve blood transfusion(s) for both children and adults. Because of the need for life sustaining transfusions, blood donations are always needed. Blood, like many other genetic factors, is best matched among people of the same ethnicity.

    The best match for Sickle Cell patients will most likely come from an African American Donor. In recent years, some American Red Cross chapters in partnership with interested sickle cell organizations launched the “Blue Tag Program.” The Program is a way to increase the diversity of the community blood supply and educate African-American’s about how their blood donation can help specific patients. African-Americans represent 12 to 14% of the U.S. population, but only 1% of the African-American community donates blood. African Americans have been historically underrepresented in the blood donor population. This makes it more challenging for the Red Cross to find the unique donor matches needed to treat Sickle Cell patients (800-RED-CROSS).

Blood donors that identify as African-American or Black, can have a “Blue Tag” attached to their blood collection bag. This shows that a donated unit might be a good match for a patient with SCD. If a patient with SCD does not need the blood within 21 days, or there is no match, the donated blood will be made available for any patient in need. Increasing the available supply of closely matched blood for SCD patients is essential. Join us in this worthy cause and host a Blue Tag Blood Donoe Drive.  Donna Monroe, MS

                                                                We've Moved

    TOVA Community Center

Sickle Cell Specialty Center

213 Greenhill Ave.

Wilmington, DE 19805

(302) 429-5870 ext. 120

contact@tovacommunityhealth.org

Your Health Matters: Sickle Cell Lives Matter TM

Your Health Matters: Sickle Cell Lives Matter TM:     TOVA Sickle Cell Specialty Center will be relocating in June to Family Medicine at Greenhill in Wilmington Delaware. Due to failed negot...

Your Health Matters: Message from Dr. Nina: Small Business of the Year

Your Health Matters: Message from Dr. Nina: Small Business of the Year: Winning Delaware’s 2017 Small Woman-Owned Business of the Year has been one of the most proudest moments in my career. To my surprise, bein...

Message from Dr. Nina: Small Business of the Year

Winning Delaware’s 2017 Small Woman-Owned Business of the Year has been one of the most proudest moments in my career. To my surprise, being recognized for work in Sickle Cell Disease (SCD) by the business community brings great joy to my heart. Sickle Cell is a Rare Disease. Without public and private resources, TOVA is challenged to sustain programs that increase access to high quality of care. Creating an innovative model of care challenges the medical community to utilize a variety of healthcare professionals in a team approach. I want to thank SCORE Delaware and the SBA for their mentorship and support. My advice to entrepreneurs is to have tenacity despite facing numerous barriers. Never give up on your goals and keep on grinding. For more information visit, www.sba.gov.  All the best, Dr. Nina